Study | Exclusion reasons | Remarks | Reference(s) | ||
---|---|---|---|---|---|
EMPHASIS-lung, 2017 | randomized controlled trial | The final analysis of EMPHASIS-lung did not show a differential effect on PFS for erlotinib versus docetaxel |
Smit EF J Thorac Oncol 2017; 12:752-762-. 10.1016/j.jtho.2016.12.017 |